Aims and Scope

Journal of Exploratory Research in Pharmacology (JERP) publishes original innovative exploratory research articles, state-of-the-art reviews, editorials, short communications that focus on novel findings and the most recent advances in basic and clinical pharmacology, covering topics from drug research, drug development, clinical trials, and application. The exploratory research published in JERP may not necessarily be conclusive, but the study design must be solid, the methodologies must be reliable, the results must be true, and the conclusions must be rational and justifiable with evidence. Topics included, but not limited to the following areas will be considered for publication in JERP.

• Drug composition and properties
• Synthesis and design of drugs and potential drugs
• Molecular/cellular and organ/system mechanisms
• Signal transduction/cellular communications/interactions
• Toxicology
• Chemical biology
• Molecular/biomarker diagnostics
• Therapeutics
• Medical applications
• Interventional (phases I-IV) clinical trials
• Observational (post-marketing) clinical studies on investigational new drugs
• Pharmacogenetics
• Pharmacoepigenetics
• Pharmacokinetics
• Pharmacodynamics
• Molecular Pharmacology
• Transgenic models

Journal of Exploratory Research in Pharmacology (JERP) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open access journal are subject to the same rigorous peer-review and quality control as in scholarly subscription journals.

JERP recognizes the distinct advantages of using an open access publication model to timely disseminate innovative and important research findings. Unrestricted free access to our publications is anticipated to foster intellectual discourse across geographic and disciplinary boundaries. To support the success of our open access approach, we ensure the integrity and high quality of research published in our journal by practicing a rigorous peer review process and by following strict guidelines for ethics in publication and in conduct of the scientific process.

All manuscripts submitted to JERP must meet the following criteria for publication:

• Topics with timely relevance to the general field or specialties in basic and clinical pharmacology;
• A must-have section of “hypothesis/ future direction/ prospect/ prediction” included for all research and review articles;
• Results and findings that have not been previously published elsewhere;
• Research performed with adherence to accepted global standards for ethics in the scientific process;
• Ethical reporting of data to protect the rights and privacy of study participants;
• Appropriate statistical analyses, with sufficient descriptions of all statistical methods used;
• Conclusions supported by the data presented;
• All funding sources and their roles cited;
• For clinical trials, the registration number cited;
• Manuscript written in standard American (US) English and formatted according to the journal-specific guidelines;
• No instances of textual plagiarism, including ‘text recycling/self-plagiarism”.

JERP currently publishes 4 issues a year, in March, June, September, and December.

JERP Metrics (2023)
Acceptance rate: 33% 
Median time from submission to first decision: 20 days 
Median time from acceptance to online publishing: 26 days

JERP adopts the open access publishing model. Revenues are generated from article processing charges, permission fees, and reprints.

JERP is owned and published by Xia & He Publishing Inc.